Instituto Dante Pazzanese de Cardiologia
Instituto Dante Pazzanese de Cardiologia
São Paulo, Brazil7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-10-06 | NCT04273945 | |
| A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT05757869 | |
| A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) | Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy | Active, not recruiting | Phase 3 | 2026-09-22 | NCT06081894 | |
| An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) | Nutritional and Metabolic Diseases, amyloidosis, metabolic disease, proteostasis deficiencies | Enrolling by invitation | Phase 3 | 2026-04-17 | NCT05667493 | |
| Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM | aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Enrolling by invitation | Phase 2 / Phase 3 | 2026-01-22 | NCT04848506 | |
| Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System | cardiovascular disorder, heart disorder | Recruiting | Not applicable | 2025-06-29 | NCT04861805 | |
| Munich Transcatheter Mitral Valve Safety and Effectiveness | cardiovascular disorder, heart disorder, heart failure, heart valve disorder, mitral valve disorder, mitral valve insufficiency | Not yet recruiting | Not applicable | 2023-07-11 | NCT05871983 |